You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Australia approves AstraZeneca vaccine, PM Morrison to be vaccinated

Pfizer's product will be available in Australia next week. It will be given in two doses three weeks apart, while AstraZeneca's will be administered in two doses 12 weeks apart

Topics
AstraZeneca | Coronavirus Vaccine | Coronavirus Tests

AP  |  Canberra 

AstraZeneca
The U.S. Food and Drug Administration authorized the trial to resume Friday. (Bloomberg)

Australia's regulator on Tuesday approved the vaccine as its second for use against COVID-19.

Pfizer's product will be available in Australia next week. It will be given in two doses three weeks apart, while AstraZeneca's will be administered in two doses 12 weeks apart.

Prime Minister Scott Morrison said the Therapeutic Goods Administration, the regulator, found the vaccine was safe and effective.

Health Minister Greg Hunt said the vaccine will prevent serious COVID-19 illness.

Morrison will be vaccinated with the Pfizer product and Hunt with AstraZeneca in a demonstration of confidence in both vaccines.

Australia has contracted 53.8 million doses of the AstraZeneca vaccine, and 50 million of those will be manufactured in Australia.

The government has also secured 20 million Pfizer vaccines for a population of 26 million.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, February 16 2021. 13:05 IST
RECOMMENDED FOR YOU